LAWRENCE, Mass., Nov. 7, 2014 /PRNewswire/ -- NxStage Medical,
Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis
products, today announced that Jeffrey H.
Burbank, Chief Executive Officer, and Matthew W. Towse, Chief Financial Officer, will
participate in the following schedule of investor conferences. A
webcast of the event will be made available at
http://ir.nxstage.com/ at the time of each conference.
Stephens 2014 Fall Investment Conference
The New York
Palace Hotel
New York, NY
Tuesday, November 11, 2014
2:00 pm ET
26th Annual Piper Jaffray Healthcare
Conference
The New York Palace Hotel
New York, NY
Wednesday, December 3, 2014
1:00 pm ET
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device
company, headquartered in Lawrence,
Massachusetts, USA, that develops, manufactures and markets
innovative products for the treatment of end-stage renal disease,
or ESRD, and acute kidney failure. For more information on NxStage
and its products, please visit the Company's website at
http://www.nxstage.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
All statements contained in this release that are not clearly
historical in nature are forward-looking, and the words
"anticipate," "believe," "expect," "estimate," "plan," and similar
expressions are generally intended to identify forward-looking
statements. Examples of these forward-looking statements include
statements as to Messrs. Burbank and Towse's plans to present at
these conferences. NxStage specifically disclaims any obligation to
update these forward-looking statements. These forward-looking
statements should not be relied upon as representing NxStage's
expectations or beliefs as of any date subsequent to the date of
this press release.
Contact:
Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
SOURCE NxStage Medical, Inc.